Current controversies in spondyloarthritis: SPARTAN

10Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

The Spondyloarthritis Research and Therapy Network (SPARTAN), founded in 2003 to promote research, education, and treatment of ankylosing spondylitis (AS) and related forms of spondyloarthritis (SpA), held its 7th Annual Research and Education Meeting in July 2009 in Houston, Texas. Current controversies in SpA discussed during the meeting included an update on the epidemiology of AS, axial SpA, and inflammatory back pain; the adequacy of the mSASS to assess radiographic involvement; the helpfulness of magnetic resonance imaging in assessing disease progression; the reliability of metrology in assessing damage; and whether biologic agents alter the course of AS. Presentations also were made on psoriasis in the SCID mouse model; the challenges and opportunities of SpA in China; a discussion of the special needs in managing SpA in Ibero-America, and the SPARK Survey in Europe and North America. The Journal of Rheumatology Copyright © 2010. All rights reserved.

Cite

CITATION STYLE

APA

Weisman, M., Learch, T. J., Baraliakos, X., Chandran, V., Gladman, D. D., Raychaudhuri, S. P., … Clegg, D. O. (2010). Current controversies in spondyloarthritis: SPARTAN. In Journal of Rheumatology (Vol. 37, pp. 2617–2623). https://doi.org/10.3899/jrheum.100890

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free